London / New York 18 May 2021 – Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS), (the “Company” or “Tiziana”), a biotechnology company focused on innovative therapeutics for oncology,
Huge honour to support Ride4Rahma Challenging 70-mile ride from Dewsbury to the historic city of York to raise funds for ongoing projects in the Balkans registration charity, please donating here & share
Tiziana Life Sciences Interview to Air on Bloomberg Television U.S. on the RedChip Money Report
Tiziana Life Sciences to participate in a Fireside Chat on 28 April 2021 at 10:30 a.m. EDT
Part of the raison d’etre of #StockMarketWatch is to fill in the gaps left by the mainstream media.
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview in this video charting update.
NEW YORK and LONDON, April 13, 2021 – Tiziana Life Sciences plc (NASDAQ: TLSA; LSE: TILS), today announced that its former subsidiary, Accustem Sciences Limited (“Accustem”), intends to file a
Part of the raison d’etre of #StockMarketWatch is to fill in the gaps left by the mainstream media.
Grab a coffee, settle down and listen to the guy’s view – thoughts covering this week in the markets. New and exclusive to Share Talk
We still have the run-up to the end of the tax year/beginning of the new ISA on April 6 as a factor in the small-cap market. The effect of this
Part of the raison d’etre of #StockMarketWatch is to fill in the gaps left by the mainstream media.
